Fig. 2From: Dysregulation of CCAAT/enhancer binding protein-alpha (CEBPA) expression in the bone marrow of acute myeloid leukemia patientsAssociation between CEBPA gene dysregulation and FLT3 mutation with a bone marrow cellularity, b cytogenetic risk, c total leukocyte count, and d peripheral blood blastBack to article page